As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...

The PBM system intentionally blocks lower-cost, FDA-approved biosimilars from being available to patients. Biosimilars are the commonsense, bipartisan solution to out-of-control prescription drug ...

Pharmacy Benefit Managers (PBM) sit in the center of our prescription drug system, coordinating between insurance companies, ...

Legislation providing more scrutiny for pharmacy benefit managers (PBMs) that failed to make it through Congress in the ...

An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.

At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report ...

The National Association of Chain Drug Stores released a video that explains how PBMs operate and how states and Congress are ...

Arbitrator Stuart Widman found that Prime violated federal and state antitrust laws by engaging in price-fixing agreements with Express Scripts, another major PBM, according to a Jan. 23 news release ...

City attorneys allege major Pharmacy Benefit Managers (PBMs) and insulin manufacturers are conspiring to artificially inflate ...

The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...